Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Recruiting
Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients
NCT06395285· Phase 1· Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm)· Source
Contact: Sarah Hussain
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error